The emerging approach of the medication represents a exciting advance in the management of diabetes mellitus type 2. Unlike existing drugs, tirzepatide targets two pathways – the GLP-1 hormone and GIP – providing https://tirzepatidepeptide471928.bligblogging.com/42741113/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment